Intracerebral Hemorrhage: A Common and Devastating Disease in Need of Better Treatment

Area of Science:

• Neurology
• Neurosurgery
• Critical Care Medicine

Background:

• Intracerebral hemorrhage (ICH) is a severe neurological condition with a poor natural history and significant patient burden.
• Current treatment options for ICH are limited, highlighting the need for more effective therapeutic strategies.
• Secondary brain injury following ICH contributes to poor patient outcomes.

Purpose of the Study:

• To review the natural history and current management of intracerebral hemorrhage (ICH).
• To discuss ongoing clinical trials evaluating minimally invasive clot evacuation techniques for ICH.
• To explore future research directions for optimizing ICH treatment.

Main Methods:

• A selective review of recent clinical trials and supportive research concerning ICH treatment was conducted.
• Emphasis was placed on evaluating minimally invasive techniques for clot removal.
• Data from trials such as Minimally Invasive Surgery plus tPA for ICH Evacuation (MISTIE) and Clot Lysis: Evaluating Accelerated Resolution (CLEAR) were surveyed.

Main Results:

• Completed trials of both medical and surgical management for ICH were reviewed.
• Research supporting clot evacuation to mitigate secondary injury was surveyed.
• Current data on minimally invasive clot removal techniques, including MISTIE, CLEAR, and endoscopic evacuation, were comprehensively discussed.

Conclusions:

• New minimally invasive treatments for ICH are under active development.
• The neurosurgical community is encouraged to advance therapies for ICH.
• Continued aggressive research into ICH treatment is crucial due to its significant societal impact and poor prognoses.